Risk factors for ocular neovascularization after central retinal artery occlusion

被引:10
作者
Lo, Wen-Jung [1 ,2 ]
Lin, Yu-Ching [1 ]
Chang, Hsin-Yi [3 ]
Chen, Mei-Ju [1 ,2 ]
机构
[1] Taipei Vet Gen Hosp, Dept Ophthalmol, 201,Sect 2,Shi Pai Rd, Taipei 112, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Ophthalmol, Taipei, Taiwan
[3] Shin Kong Wu Ho Mem Hosp, Dept Ophthalmol, Taipei, Taiwan
关键词
Central retinal artery occlusion; Chronic kidney disease; Dialysis; Glaucoma; Ocular neovascularization; Risk factor; ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL BEVACIZUMAB; IRIS NEOVASCULARIZATION; DIABETIC-RETINOPATHY; ISCHEMIC SYNDROME; AQUEOUS-HUMOR; OBSTRUCTION; SECONDARY;
D O I
10.1097/JCMA.0000000000000766
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To report the incidence and risk factors associated with ocular neovascularization (NV) in patients with central retinal artery occlusion (CRAO). Methods: This retrospective study included patients diagnosed with acute CRAO in a single tertiary center. Medical charts were reviewed for ocular NV occurrences. We analyzed systemic and ocular conditions on first visit and demographic data. Results: Eighty-seven eyes were eligible for this study. Among these, 13 eyes had ocular NV after CRAO, with an incidence of 15%. The prevalences of hypertension, diabetes mellitus, history of stroke, chronic kidney disease (CKD), and age at first visit were higher among patients with ocular NV than among patients without ocular NV after CRAO. Moreover, most patients with CKD in the ocular NV group had undergone dialysis. A multivariate regression analysis revealed that CKD (hazard ratio [HR]: 9.27, 95% CI, 1.87-46.05, p = 0.006) and glaucoma history (HR: 7.52, 95% CI, 1.14-49.46, p = 0.036) were significant risk factors for developing ocular NV among patients with CRAO. Conclusion: CKD and glaucoma history were significant risk factors for developing ocular NV after CRAO, particularly among patients that underwent dialysis.
引用
收藏
页码:880 / 885
页数:6
相关论文
共 30 条
[1]   Retinal and Choroidal Changes and Visual Outcome in Central Retinal Artery Occlusion: An Optical Coherence Tomography Study [J].
Ahn, Seong Joon ;
Woo, Se Joon ;
Park, Kyu Hyung ;
Jung, Cheolkyu ;
Hong, Jeong-Ho ;
Han, Moon-Ku .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2015, 159 (04) :667-676
[2]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[3]   THE OCULAR ISCHEMIC SYNDROME - CLINICAL, FLUORESCEIN ANGIOGRAPHIC AND CAROTID ANGIOGRAPHIC FEATURES [J].
BROWN, GC ;
MAGARGAL, LE .
INTERNATIONAL OPHTHALMOLOGY, 1988, 11 (04) :239-251
[4]   MACULAR THICKNESS MEASUREMENTS IN CENTRAL RETINAL ARTERY OCCLUSION BY OPTICAL COHERENCE TOMOGRAPHY [J].
Chen, San-Ni ;
Hwang, Jiunn-Feng ;
Chen, Yan-Ting .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (04) :730-737
[5]   Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma [J].
Ciftci, Suleyman ;
Sakalar, Yildirim Bayezit ;
Unlu, Kaan ;
Keklikci, Ugur ;
Caca, Ihsan ;
Dogan, Eyup .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2009, 19 (06) :1028-1033
[6]   Central retinal artery occlusion without underlying chronic ocular ischemic syndrome may lead to neovascular glaucoma [J].
Degoumois, A. ;
Miocque, S. ;
Denion, E. .
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (09) :758-762
[7]   A PROSPECTIVE-STUDY OF ACUTE CENTRAL RETINAL ARTERY OBSTRUCTION - THE INCIDENCE OF SECONDARY OCULAR NEOVASCULARIZATION [J].
DUKER, JS ;
SIVALINGAM, A ;
BROWN, GC ;
REBER, R .
ARCHIVES OF OPHTHALMOLOGY, 1991, 109 (03) :339-342
[8]  
DUKER JS, 1988, OPHTHALMOLOGY, V95, P1244
[9]   VEGF and Intraocular Neovascularization: From Discovery to Therapy [J].
Ferrara, Napoleone .
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2016, 5 (02)
[10]   The role of growth factors in the pathogenesis of diabetic retinopathy [J].
Grant, MB ;
Afzal, A ;
Spoerri, P ;
Pan, H ;
Shaw, LC ;
Mames, RN .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (10) :1275-1293